Suggestions
Eric David
CEO of Gene Therapy at BridgeBio
Professional Background
Eric David is a distinguished leader in the healthcare and biotechnology sectors, deeply committed to advancing gene therapy and innovative medical practices. As the current CEO of Gene Therapy at BridgeBio, he spearheads initiatives that focus on harnessing the power of genetic medicine to develop transformative treatments for various diseases. His leadership at BridgeBio represents a culmination of years of extensive experience and professional development in the fields of medicine and law.
Before assuming his role at BridgeBio, Eric played a pivotal role in shaping the landscape of healthcare through his contributions to Organovo Holdings, Inc., where he served as Co-founder, Chief Strategy Officer, and Executive Vice President of Preclinical Development. His strategic insights and hands-on experience significantly contributed to the company’s mission of propelling 3D bioprinting technologies into the forefront of medical research and application.
Eric's career journey reflects a diverse blend of clinical excellence and business acumen. He began with a robust medical foundation as Assistant Chief Resident in Internal Medicine at New York Presbyterian Hospital, where he honed his clinical skills and developed a deep understanding of patient care. This clinical experience laid a strong groundwork for his later ventures in the business realm. Additionally, he held an Associate Principal position at McKinsey & Co, where he provided consultancy services that combined analytical rigor with strategic decision-making for healthcare organizations.
Education and Achievements
Eric David's educational background is as multifaceted as his career. He earned his Doctor of Medicine (MD) degree from the prestigious Columbia University College of Physicians and Surgeons, a step that solidified his expertise in medicine and patient care. Following this, he pursued a Juris Doctor (JD) with a focus on Intellectual Property, Environmental Law, and Healthcare Law at Columbia Law School. This unique combination of medical and legal education empowers Eric to navigate the complexities of healthcare regulations and intellectual property rights effectively, positioning him as a key advocate for innovation in medical technology.
Eric also holds a Bachelor of Arts (BA) degree in Physics and Fine Arts from Amherst College. This diverse academic training not only fosters his analytical thinking but also enhances his appreciation for the intersection of science and art, broadening his perspective in developing innovative healthcare solutions.
Notable Achievements
Throughout his career, Eric has demonstrated a strong commitment to both professional excellence and community service. He has served as a Board Member at the HealthCare Chaplaincy Network, contributing to the organization's mission to enhance spiritual care within healthcare settings. His involvement reflects his understanding of the holistic approach to healing, encompassing not only the physical but also the emotional and spiritual well-being of patients.
Eric's journey is a testament to his unwavering dedication to improving healthcare through innovation, strategic thinking, and cross-disciplinary expertise. From his roots in medicine to his ventures in biotechnology and legal frameworks, he continuously strives to make a significant impact in the medical field. His forward-thinking leadership at BridgeBio and past experiences showcase his unique ability to integrate scientific advancement with an understanding of legal and ethical considerations in healthcare.